“…However, these inter esting observations have not been confirmed by others [23,24], Evidently, prospective studies involving larger numbers of patients are needed to resolve the problem. While it is tempting to attribute the reported difference in graft survival in patients with different HBsAg and antiHBs status to differences in the immunocompétence of the patients, Rashid et al [21], apart from showing that all their 7 patients with anti-HBs antibodies have one or more preformed antibodies against one or more HLA antigens, have failed to demonstrate any difference in immuno compétence of the lymphocytes between the different groups by in vitro techniques.…”